Edition:
United States

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.16USD
16 Feb 2018
Change (% chg)

$-0.05 (-4.13%)
Prev Close
$1.21
Open
$1.23
Day's High
$1.23
Day's Low
$1.16
Volume
52,583
Avg. Vol
44,013
52-wk High
$3.06
52-wk Low
$1.07

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.258
Jun '17 0.00 -0.232
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.00 -0.344
Sep '16 0.00 -0.426
Jun '16 0.00 -0.493
Mar '16 0.00 0.910
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -0.23 -0.23 -0.23 --
Quarter Ending Jun-18 1 -0.24 -0.24 -0.24 --
Year Ending Dec-18 1 -0.96 -0.96 -0.96 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.03 34.43
P/E High - Last 5 Yrs. -- 41.47 46.75
P/E Low - Last 5 Yrs. -- 23.35 24.14
Beta 0.77 0.81 0.81
Price to Sales (TTM) -- 6.26 8.57
Price to Book (MRQ) 2.04 4.27 5.14
Price to Tangible Book (MRQ) 3.07 4.76 6.30
Price to Cash Flow (TTM) -- 22.77 25.75
% Owned Institutions 13.59 1.27 2.33

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.26 5.27
Payout Ratio(TTM) -- 45.36 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.53 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.35 7.30
Sales - 5 Yr. Growth Rate -- 9.90 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.52 16.64 20.15
EPS (TTM) vs TTM 1 Yr. Ago -197.81 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.48
Capital Spending - 5 Yr. Growth Rate -9.41 14.63 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.38 2.42
Current Ratio (MRQ) 3.14 3.33 3.38
LT Debt to Equity (MRQ) 0.04 8.98 11.85
Total Debt to Equity (MRQ) 0.08 12.06 15.12
Interest Coverage (TTM) -- 44.83 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.25 54.90
Gross Margin - 5 Yr. Avg. -- 52.61 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.52 9.86
Operating Margin (TTM) -- 11.43 1.25
Operating Margin - 5 Yr. Avg. -- 14.30 5.07
Pre-Tax Margin (TTM) -- 11.82 2.12
Pre-Tax Margin - 5 Yr. Avg. -- 14.58 5.33
Net Profit Margin (TTM) -- 8.21 -1.38
Net Profit Margin - 5 Yr. Avg. -- 10.92 1.62
Effective Tax Rate (TTM) -- 22.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 23.57 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 919,747,049 819,569,446
Net Income/Employee (TTM) -804,579 107,578,762 95,804,981
Receivable Turnover (TTM) -- 5.29 5.40
Inventory Turnover (TTM) -- 2.59 3.48
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -125.93 11.11 10.68
Return on Assets - 5 Yr. Avg. -75.22 12.64 12.00
Return on Investment (TTM) -154.64 14.00 13.54
Return on Investment - 5 Yr. Avg. -115.63 16.55 15.72
Return on Equity (TTM) -157.67 15.34 14.80
Return on Equity - 5 Yr. Avg. -127.41 17.61 16.91
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 80.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.69%
# of Holders: 23
Total Shares Held: 2,164,961
3 Mo. Net Change: 1,287,483
# New Positions: 7
# Closed Positions: 1
# Increased Positions: 11
# Reduced Positions: 1
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.